DAA1946 |
vitamin E levels decrease |
Molecular |
blood |
Mouse |
— |
— |
|
DAA673 |
telomere length in hematopoietic stem cells |
Molecular |
hematopoietic stem cells |
Human |
— |
— |
|
DAA877 |
Higher oxidation and decreased proteasome activity |
Molecular |
epidermis |
Human |
— |
— |
|
DAA1986 |
telomere shortening |
Molecular |
leukocyte |
Human |
— |
— |
|
DAA1998 |
Lipid oxidation increased with age in males |
Molecular |
skin |
Human |
— |
— |
|
DAA959 |
telomere shortening |
Molecular |
naïve T cell |
Human |
— |
— |
|
DAA901 |
telomere shortening |
Molecular |
kidney |
Human |
— |
— |
|
DAA989 |
telomere shortening |
Molecular |
lymphocytes |
Human |
— |
— |
|
DAA849 |
telomere shortening |
Molecular |
liver |
Human |
— |
— |
|
DAA2042 |
Increase in IgA and IgM |
Molecular |
oral cavity |
Human |
— |
— |
|
DAA1067 |
transporter activity decreases |
Molecular |
blood brain barrier |
Human |
— |
— |
|
DAA890 |
IgM deposition in glomeruli |
Molecular |
glomerulus |
Human |
— |
— |
|
DAA1211 |
blood HSP70 level increase |
Molecular |
plasma |
Human |
— |
— |
|
DAA2055 |
Circulating miR-21 expression increases |
Molecular |
blood |
Human |
— |
— |
|
DAA1973 |
5-hmC increase in cerebrellum |
Molecular |
cerebellum |
Mouse |
— |
— |
|
DAA1967 |
Alox5 arachidonate 5-lipoxygenase (5-LOX) mRNA expression increase |
Molecular |
cerebellum |
Mouse |
— |
— |
|
DAA2038 |
Concentration of cell free DNA increases |
Molecular |
plasma |
Human |
— |
— |
|
DAA1966 |
Alox5 arachidonate 5-lipoxygenase (5-LOX) promoter methylation increase |
Molecular |
hippocampus |
Mouse |
— |
— |
|
DAA2047 |
creatinine levels increase |
Molecular |
plasma |
Human |
— |
— |
|
DAA1231 |
decreased NF-KappaB induction in T cells |
Molecular |
T cell |
Human |
— |
— |
|
DAA1961 |
Intracellular NAD+ concentration decreases |
Molecular |
bone marrow |
Mouse |
— |
— |
|
DAA1232 |
decreased proteasomal activity in T cells |
Molecular |
T cell |
Human |
— |
— |
|
DAA1997 |
DNA damage increases with age |
Molecular |
skin |
Human |
— |
— |
|